Document is current
Any future updates will be listed below
-
Authors
Hara, Azusa http://orcid.org/0000-0001-6958-7864
Hirata, Takumi http://orcid.org/0000-0003-2899-6762
Okamura, Tomonori http://orcid.org/0000-0003-0488-0351
Kimura, Shinya http://orcid.org/0000-0003-1525-8680
Urushihara, Hisashi http://orcid.org/0000-0001-6913-9930
- License Information
-
More Information
Article History
Received: 23 June 2021
Accepted: 24 September 2021
First Online: 9 October 2021
Declarations
:
: The study protocol was approved by the Keio University Faculty of Pharmacy ethics committee for research involving humans (No. 190509-2). Informed consent was waived because of the use of anonymous data.
: Not required.
: KS is a representative director of Japan Medical Data Center Inc., which provided data for this study. HU is a part-time consultant for Eisai Co., Ltd. and Nippon Boehringer Ingelheim Co., Ltd. and has received research funds from CAC Croit Corporation, Shionogi Pharma Co., Ltd., Daiichi-Sankyo Co., Ltd., Astellas Pharma Inc., and Mitsubishi Tanabe Pharma Corporation. All other authors declare no potential competing interests.
